Sunburn and UV Exposure in 217 Outdoor Rock Climbers
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity, training or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact study measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 217 outdoor climbers completing a validated online questionnaire; 10 also wore personal dosimeters during two climbing weekends. |
| Design | Cross-sectional survey plus a small pilot personal-dosimetry component. |
| Comparator | Reported behaviors across respondents and measured ultraviolet dose across the two pilot weekends. |
| Timepoint | Survey April–June 2021; dosimetry in May and November 2021. |
| Key result | 65.9% reported at least one sunburn in the previous climbing season. Sunscreen SPF 15 or higher was reported by 49.3%, sunglasses by 47% and two-hour sunscreen reapplication by 14.3%. |
| Funding/conflict context | Funding and author-conflict details were not reported in the accessible PubMed abstract. |
What was actually measured?
65.9% reported at least one sunburn in the previous climbing season. Sunscreen SPF 15 or higher was reported by 49.3%, sunglasses by 47% and two-hour sunscreen reapplication by 14.3%.
The study combines a broad behavior survey with direct exposure measurement, but only 10 people contributed dosimetry. Self-report and measured dose answer different questions.
The denominator defines the claim. People, visits, infections, episodes, isolates, feet and blisters are different analytic units. A percentage or rate using one unit cannot be silently rewritten as the percentage of people affected.
What the result does not prove
The online sample may overrepresent engaged climbers, sunburn was recalled and the dosimetry pilot was very small. The study did not measure long-term skin outcomes.
Association and timing do not automatically prove individual causation. Footwear, surfaces, climate, ultraviolet exposure, hygiene, protective equipment, training load, prior conditions, referral patterns and access to care may change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.
Sun and altitude boundary: Moisturization does not replace broad-spectrum sunscreen, protective clothing, shade, weather planning, cold-injury prevention or medical evaluation.
Keep the condition categories separate
Dryness, friction injury, sunburn, dermatitis, sensitization, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose infection, prevent ultraviolet injury, replace medical evaluation or substitute for activity-specific prevention.
Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms, a suspected contagious outbreak or major loss of function warrants prompt professional assessment. Clinicians may need microscopy, culture, patch testing, skin-prick testing or other targeted evaluation depending on the question.
Activity details worth documenting
- What surface, footwear, sock, glove, mat, pool, boat, uniform, animal, climate or training load preceded the change?
- Where did the problem begin, and did it change during rest, travel, deployment, competition or a different facility?
- Were towels, clothing, footwear, razors, equipment or showers shared, and how were high-touch surfaces cleaned?
- How often was skin wet, occluded, rubbed, heated, chilled or exposed to sun?
- Did the problem alter sleep, pace, attendance, training, competition, work safety or duty status?
Prevention comes before cosmetic care
Prevention should match the hazard: well-fitted and broken-in equipment, task-appropriate textiles, friction management, clean personal gear, facility hygiene, prompt showering, ultraviolet protection and timely clinical assessment. No single intervention prevents every diagnosis.
Do not share personal skin products during an outbreak and do not test workplace, sport or environmental materials directly on skin. Follow occupational-health, sports-medicine, public-health and facility instructions for contagious or exposure-related conditions.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 37847459
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: sun protection
- American Academy of Dermatology: dry-skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, infection, blisters, sunburn or sensitization; relieves pain or itch; neutralizes environmental exposures; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Foot-Blister Risk Factors in 339 Cadets After a 21-km March
- Photoprotection Reports From 78 Olympic-Level Aquatics Athletes
- Skin-Related Disorders During a 77-Athlete Ultratrail
- Sunburn and Skin Screening at a 1,145-Athlete Extreme Race
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, sports, military, maritime, animal-exposure or infection-control determination.